Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Brazil Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20081
20092
20101
20111
20133
20141
20151
20181
20191
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Terminated3
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Forest Laboratories2
Ministry of Health, Brazil2
Novartis Pharmaceuticals2
Scitech Produtos Medicos SA2
Bayer1
CSL Behring1
ECRI bv1
Eli Lilly and Company1
Hospital de Clinicas de Porto Alegre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease20
Heart Diseases4
Myocardial Infarction4
Stroke4
Cardiovascular Diseases3
Heart Failure3
Myocardial Ischemia3
Peripheral Arterial Disease3
Acute Coronary Syndrome2
Angina Pectoris2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.